Immunovia AB (publ) IMMNOV.ST
IMMNOV.ST
Immunovia AB (publ) ICO.ST
Iconovo AB (publ) NICA.ST
Nanologica AB (publ) BIOVIC-B.ST
Biovica International AB (publ) NXTCL.ST
NextCell Pharma AB PILA.ST
Pila Pharma AB (publ) LXB.ST
Luxbright AB (publ) SPAGO.ST
Spago Nanomedical AB (publ) SCIB.ST
SciBase Holding AB (publ) LPGO.ST
Lipigon Pharmaceuticals AB (publ)
Immunovia AB (publ) ICO.ST
Iconovo AB (publ) NICA.ST
Nanologica AB (publ) BIOVIC-B.ST
Biovica International AB (publ) NXTCL.ST
NextCell Pharma AB PILA.ST
Pila Pharma AB (publ) LXB.ST
Luxbright AB (publ) SPAGO.ST
Spago Nanomedical AB (publ) SCIB.ST
SciBase Holding AB (publ) LPGO.ST
Lipigon Pharmaceuticals AB (publ)
Performance
| Periode | IMMNOV.ST | ICO.ST | NICA.ST | BIOVIC-B.ST | NXTCL.ST | PILA.ST | LXB.ST | SPAGO.ST | SCIB.ST | LPGO.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 22.18 % | 73.66 % | 31.05 % | -12.50 % | -19.22 % | -26.81 % | 1.11 % | 13.70 % | -17.29 % | 44.72 % |
| YTD | -40.26 % | -54.13 % | -28.57 % | -71.86 % | -63.43 % | -44.24 % | -19.11 % | 20.87 % | -27.34 % | 9.85 % |
| 1Y | -50.76 % | -61.71 % | -49.61 % | -72.55 % | -51.61 % | -55.41 % | -26.46 % | 13.18 % | -37.80 % | -30.59 % |
| 3Y | -99.05 % | -96.19 % | -86.83 % | -94.07 % | -88.81 % | -42.10 % | -53.63 % | -67.99 % | -91.43 % | -90.15 % |
| 5Y | -99.83 % | -96.40 % | -90.11 % | -98.49 % | -94.82 % | -75.19 % | -73.04 % | -95.36 % | -91.31 % | -98.70 % |
| 10Y | -98.82 % | -94.60 % | -92.56 % | -95.31 % | -66.82 % | -75.19 % | -73.04 % | -98.57 % | -99.00 % | -98.70 % |
| Depuis le début | -98.82 % | -94.60 % | -92.56 % | -95.31 % | -66.82 % | -75.19 % | -73.04 % | -97.88 % | -99.34 % | -98.70 % |